Xofluza: Package Insert and Label Information

XOFLUZA- baloxavir marboxil powder
Evonik Corporation

Drum Label, Baloxavir marboxil

Caution: For manufacturing, processing or repacking. Rx only.

EV022X

S-033188 API Milled

Baloxavir Marboxil (DOP13)

Caution: LIver, Potent, Suspect Reproductive

Storage conditions: 1 — 30 C

Batch number:

Manufacture Date:

Manufactured and tested by Evonik Corporation, Tippecanoe Laboratories, 1650 Lilly Road, Lafayette, IN 47909

Baloxavir Marboxil
(click image for full-size original)

Warehouse put-away label, net weight

Product is weighed in the warehouse and the weight is on this label. Label also includes the storage location (in the warehouse) and the SAP transfer order#.

Material number : EV022X

Material description:

Batch:

TO:

SU: storage unit

Quantity: x.xx Kg

Generic warehouse Kg label
(click image for full-size original)

May 2022 Warehouse KG label

S-033188 API Milled

Put-Away Label

Material Number 99144221

Storage Unit

Net Weight xx Kg

Lot/Batch

Old Material Number EV022X

QR code box

Temperature Conditions: 1 to 30°C

Hazards:

Liver Potent Suspect Reproductive

Health (U) Unknown

Fire (U) Unknown

Reactivity (U) Unknown

Special P (highly potent)

Evonik Corporation

1650 Lilly Road Lafayette, Indiana 47909 USA

Phone: 765-477-4300 Fax: 765-477-4291

Evonik: Leading beyond Chemistry

Emergency Information: Chemtrec 800-424-9300

Warehouse_KG_May2022
(click image for full-size original)
XOFLUZA
baloxavir marboxil powder
Product Information
Product Type BULK INGREDIENT Item Code (Source) NHRIC:62128-0394
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BALOXAVIR MARBOXIL (BALOXAVIR MARBOXIL) BALOXAVIR MARBOXIL 1 kg in 1 kg
Packaging
# Item Code Package Description Multilevel Packaging
1 NHRIC:62128-0394-1 5 kg in 1 DRUM None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Export only 03/01/2022
Labeler — Evonik Corporation (130890994)

Revised: 06/2022 Evonik Corporation

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2022. All Rights Reserved.